Dorota Lubanska, Ph.D.
Affiliations: | 2013 | BIOLOGICAL SCIENCES | University of Windsor, Windsor, Canada |
Area:
Molecular Biology, Neuroscience Biology, OncologyGoogle:
"Dorota Lubanska"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Lisa A. Porter | grad student | 2013 | University of Windsor | |
| (Novel Regulation of the Cell Cycle During Cell Fate Decisions in the Central Nervous System.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lubanska D, Alrashed S, Oschanney L, et al. (2023) E-learning and research experience exchange in the online setting of student peer mentor network during COVID-19 pandemic and beyond: A laboratory case study. Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology |
| Fidalgo da Silva E, Abu Khatir B, Drouillard C, et al. (2022) Tuberin levels during cellular differentiation in brain development. Differentiation; Research in Biological Diversity. 130: 43-50 |
| Lubanska D, Alrashed S, Mason GT, et al. (2022) Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles. Scientific Reports. 12: 12078 |
| Lubanska D, Qemo I, Byrne M, et al. (2021) The Cyclin-Like Protein SPY1 overrides Reprogramming Induced Senescence Through EZH2 Mediated H3K27me3. Stem Cells (Dayton, Ohio) |
| Bakht MK, Lovnicki JM, Tubman J, et al. (2019) Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for FDG imaging of PSMA-suppressed tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Lubanska D, Porter L. (2017) Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme. Drugs in R&D |
| Lubanska D, Porter LA. (2014) The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population. Oncoscience. 1: 336-48 |
| Lubanska D, Porter LA. (2014) Atypical cell cycle control over neural cell fate. Cell Cycle (Georgetown, Tex.). 13: 2987 |
| Lubanska D, Market-Velker BA, deCarvalho AC, et al. (2014) The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma. Cancer Cell. 25: 64-76 |
| Lubanska D, Porter LA. (2014) The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population Oncoscience. 1: 336-348 |